{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:07:58Z","timestamp":1794017278220,"version":"4.8.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"PhD student supporting research project funds"},{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"publisher","award":["32012"],"award-info":[{"award-number":["32012"]}],"id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"publisher","award":["32012"],"award-info":[{"award-number":["32012"]}],"id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sanofi","award":["iEnvision tracking no. 2023ESR0000123"],"award-info":[{"award-number":["iEnvision tracking no. 2023ESR0000123"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Airway fibrosis in severe asthma is a hallmark of disease pathology, yet the mechanisms driving fibroblast activation remain incompletely understood. While interleukin-4 (IL-4) and interleukin-13 (IL-13) are central to type 2 inflammation, their combined role in directly promoting human lung fibroblast-mediated fibrosis is not well defined. This study demonstrates that IL-4 and IL-13 act synergistically on asthmatic fibroblasts to potentiate a pro-fibrotic program via the shared interleukin-4 receptor alpha (IL-4R\u03b1)\/Signal Transducer and Activator of Transcription 6 (STAT6) axis. We found that diseased human lung fibroblasts (DHLFs) from asthmatic patients exhibited elevated expression of the type II receptor (IL-4R\u03b1\/IL-13R\u03b11) compared to normal human lung fibroblasts (NHLFs), priming them for activation. Consequently, combined IL-4\/IL-13 stimulation synergistically enhanced STAT6 phosphorylation and robustly upregulated key extracellular matrix (ECM) components (collagen I\/III, fibronectin) and regulators (matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinase-1\/2 (TIMP-1\/2). Furthermore, IL-4 specifically emerged as the dominant driver of fibroblast proliferation. Critically, the IL-4R\u03b1-blocking antibody dupilumab effectively abrogated this pro-fibrotic response. These findings provide a direct mechanistic basis for targeting the IL-4R\u03b1 pathway to mitigate airway remodeling and potentially alter the progressive course of fibrosis in patients with severe, type 2-high asthma.<\/jats:p>","DOI":"10.1038\/s41598-026-54625-7","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:13:53Z","timestamp":1780128833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dupilumab attenuate IL-4 and IL-13 synergistic effect on airway remodeling in asthma via blocking IL-4R\u03b1\/STAT6 axis"],"prefix":"10.1038","volume":"16","author":[{"given":"Lina","family":"Sahnoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rola","family":"Abujabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasneem M.","family":"Alanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Mdkhana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Olivenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Pur\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam","family":"Mahboub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Laumonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"Hamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khuloud","family":"Bajbouj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qutayba","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"10258","key":"54625_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD Diseases","year":"2020","unstructured":"Diseases, G. B. D. & Injuries, C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396 (10258), 1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9 (2020).","journal-title":"Lancet"},{"issue":"1","key":"54625_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41533-023-00330-1","volume":"33","author":"ML Levy","year":"2023","unstructured":"Levy, M. L. et al. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update. NPJ Prim. Care Respir Med. 33 (1), 7. https:\/\/doi.org\/10.1038\/s41533-023-00330-1 (2023).","journal-title":"NPJ Prim. Care Respir Med."},{"key":"54625_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2024.1496392","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. Unraveling heterogeneity and treatment of asthma through integrating multi-omics data.. Front. Allergy https:\/\/doi.org\/10.3389\/falgy.2024.1496392 (2024).","journal-title":"Front. Allergy"},{"key":"54625_CR4","doi-asserted-by":"publisher","first-page":"100969","DOI":"10.1016\/j.mam.2021.100969","volume":"85","author":"G Caramori","year":"2022","unstructured":"Caramori, G. et al. Corticosteroid resistance in asthma: Cellular and molecular mechanisms. Mol. Aspects Med. 85, 100969. https:\/\/doi.org\/10.1016\/j.mam.2021.100969 (2022).","journal-title":"Mol. Aspects Med."},{"issue":"6","key":"54625_CR5","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2021.02.016","volume":"184","author":"H Hammad","year":"2021","unstructured":"Hammad, H. & Lambrecht, B. N. The basic immunology of asthma. Cell 184 (6), 1469\u20131485. https:\/\/doi.org\/10.1016\/j.cell.2021.02.016 (2021).","journal-title":"Cell"},{"issue":"5","key":"54625_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2222.2008.02958.x","volume":"38","author":"SP Hogan","year":"2008","unstructured":"Hogan, S. P. et al. Eosinophils: biological properties and role in health and disease. Clin. Exp. Allergy. 38 (5), 709\u2013750. https:\/\/doi.org\/10.1111\/j.1365-2222.2008.02958.x (2008).","journal-title":"Clin. Exp. Allergy"},{"issue":"4","key":"54625_CR7","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jaci.2018.06.002","volume":"142","author":"M Godar","year":"2018","unstructured":"Godar, M. et al. A bispecific antibody strategy to target multiple type 2 cytokines in asthma. J. Allergy Clin. Immunol. 142 (4), 1185\u20131193e. https:\/\/doi.org\/10.1016\/j.jaci.2018.06.002 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"54625_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1165\/rcmb.2006-0180OC","volume":"36","author":"G Zhen","year":"2007","unstructured":"Zhen, G. et al. IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production. Am. J. Respir. Cell Mol. Biol. 36 (2), 244\u2013253. https:\/\/doi.org\/10.1165\/rcmb.2006-0180OC (2007).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"54625_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fmed.2020.00191","volume":"7","author":"KP Hough","year":"2020","unstructured":"Hough, K. P. et al. Airway remodeling in asthma. Front. Med. (Lausanne) 7, 191. https:\/\/doi.org\/10.3389\/fmed.2020.00191 (2020).","journal-title":"Front. Med. (Lausanne)"},{"issue":"2","key":"54625_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1164\/ajrccm\/147.2.405","volume":"147","author":"N Carroll","year":"1993","unstructured":"Carroll, N. et al. The structure of large and small airways in nonfatal and fatal asthma. Am. Rev. Respir Dis. 147 (2), 405\u2013410. https:\/\/doi.org\/10.1164\/ajrccm\/147.2.405 (1993).","journal-title":"Am. Rev. Respir Dis."},{"issue":"3","key":"54625_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaci.2005.06.011","volume":"116","author":"C Pepe","year":"2005","unstructured":"Pepe, C. et al. Differences in airway remodeling between subjects with severe and moderate asthma. J. Allergy Clin. Immunol. 116 (3), 544\u2013549. https:\/\/doi.org\/10.1016\/j.jaci.2005.06.011 (2005).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"54625_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/resp.13251","volume":"23","author":"GG King","year":"2018","unstructured":"King, G. G. et al. Pathophysiology of severe asthma: We\u2019ve only just started. Respirology 23 (3), 262\u2013271. https:\/\/doi.org\/10.1111\/resp.13251 (2018).","journal-title":"Respirology"},{"issue":"6","key":"54625_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1084\/jem.194.6.809","volume":"194","author":"CG Lee","year":"2001","unstructured":"Lee, C. G. et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J. Exp. Med. 194 (6), 809\u2013821. https:\/\/doi.org\/10.1084\/jem.194.6.809 (2001).","journal-title":"J. Exp. Med."},{"key":"54625_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2147\/JAA.S267222","volume":"15","author":"C Joseph","year":"2022","unstructured":"Joseph, C. & Tatler, A. L. Pathobiology of airway remodeling in asthma: The emerging role of integrins. J. Asthma Allergy 15, 595\u2013610. https:\/\/doi.org\/10.2147\/JAA.S267222 (2022).","journal-title":"J. Asthma Allergy"},{"issue":"11","key":"54625_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1096\/fasebj.8.11.8070631","volume":"8","author":"R Raghow","year":"1994","unstructured":"Raghow, R. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J. 8 (11), 823\u2013831. https:\/\/doi.org\/10.1096\/fasebj.8.11.8070631 (1994).","journal-title":"FASEB J."},{"issue":"supp1","key":"54625_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","volume":"31","author":"A Jab\u0142o\u0144ska-Trypu\u0107","year":"2016","unstructured":"Jab\u0142o\u0144ska-Trypu\u0107, A., Matejczyk, M. & Rosochacki, S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J. Enzyme Inhib. Med. Chem. 31 (supp1), 177\u2013183. https:\/\/doi.org\/10.3109\/14756366.2016.1161620 (2016).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"24","key":"54625_CR17","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms21249739","volume":"21","author":"GA Cabral-Pacheco","year":"2020","unstructured":"Cabral-Pacheco, G. A. et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int. J. Mol. Sci. 21(24), 9739. https:\/\/doi.org\/10.3390\/ijms21249739 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"3 Pt 1","key":"54625_CR18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/s0091-6749(99)70319-2","volume":"104","author":"G Mautino","year":"1999","unstructured":"Mautino, G. et al. Balance in asthma between matrix metalloproteinases and their inhibitors. J. Allergy Clin. Immunol. 104 (3 Pt 1), 530\u2013533. https:\/\/doi.org\/10.1016\/s0091-6749(99)70319-2 (1999).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"54625_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1183\/09031936.00068712","volume":"43","author":"R F.","year":"2014","unstructured":"F., R. et al. Interleukin-13 induces collagen type-1 expression through matrix metalloproteinase-2 and transforming growth factor-\u03b21 in airway fibroblasts in asthma. Eur. Respir. J. 43(2), 464\u2013473. https:\/\/doi.org\/10.1183\/09031936.00068712 (2014).","journal-title":"Eur. Respir. J."},{"issue":"10","key":"54625_CR20","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1046\/j.1365-2222.2003.01785.x","volume":"33","author":"C Bergeron","year":"2003","unstructured":"Bergeron, C. et al. Regulation of procollagen I (\u03b11) by interleukin\u20104 in human bronchial fibroblasts: A possible role in airway remodelling in asthma. Clin. Exp. Allergy. 33(10), 1389\u201397. https:\/\/doi.org\/10.1046\/j.1365-2222.2003.01785.x (2003).","journal-title":"Clin. Exp. Allergy."},{"key":"54625_CR21","doi-asserted-by":"publisher","first-page":"100995","DOI":"10.1016\/j.mam.2021.100995","volume":"85","author":"ZI Komlosi","year":"2022","unstructured":"Komlosi, Z. I. et al. Cellular and molecular mechanisms of allergic asthma. Mol. Aspects Med. 85, 100995. https:\/\/doi.org\/10.1016\/j.mam.2021.100995 (2022).","journal-title":"Mol. Aspects Med."},{"key":"54625_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/biom14050546","author":"K Nakagome","year":"2024","unstructured":"Nakagome, K. & Nagata, M. The possible roles of IL-4\/IL-13 in the development of eosinophil-predominant severe asthma.. Biomolecules https:\/\/doi.org\/10.3390\/biom14050546 (2024).","journal-title":"Biomolecules"},{"issue":"5","key":"54625_CR23","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/all.14151","volume":"75","author":"A Le Floc\u2019h","year":"2020","unstructured":"Le Floc\u2019h, A. et al. Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation. Allergy 75 (5), 1188\u20131204. https:\/\/doi.org\/10.1111\/all.14151 (2020).","journal-title":"Allergy"},{"key":"54625_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9091096","author":"FLM Ricciardolo","year":"2021","unstructured":"Ricciardolo, F. L. M., Bertolini, F. & Carriero, V. The role of Dupilumab in severe asthma.. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines9091096 (2021).","journal-title":"Biomedicines"},{"issue":"1","key":"54625_CR25","doi-asserted-by":"publisher","first-page":"100003","DOI":"10.1016\/j.xjidi.2021.100003","volume":"1","author":"Y Imai","year":"2021","unstructured":"Imai, Y. et al. Dupilumab effects on innate lymphoid cell and helper T cell populations in patients with atopic dermatitis. JID Innov. 1(1), 100003. https:\/\/doi.org\/10.1016\/j.xjidi.2021.100003 (2021).","journal-title":"JID Innov."},{"issue":"2","key":"54625_CR26","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jaci.2020.05.037","volume":"147","author":"C Trichot","year":"2021","unstructured":"Trichot, C. et al. T(H) cell diversity and response to dupilumab in patients with atopic dermatitis. J. Allergy Clin. Immunol. 147 (2), 756\u2013759. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.037 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"26","key":"54625_CR27","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","volume":"368","author":"S Wenzel","year":"2013","unstructured":"Wenzel, S. et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl. J. Med. 368 (26), 2455\u20132466. https:\/\/doi.org\/10.1056\/NEJMoa1304048 (2013).","journal-title":"N Engl. J. Med."},{"key":"54625_CR28","doi-asserted-by":"publisher","first-page":"156091","DOI":"10.1016\/j.cyto.2022.156091","volume":"162","author":"G Scott","year":"2023","unstructured":"Scott, G. et al. IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline. Cytokine 162, 156091. https:\/\/doi.org\/10.1016\/j.cyto.2022.156091 (2023).","journal-title":"Cytokine"},{"issue":"2","key":"54625_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000073718","volume":"132","author":"A Saito","year":"2003","unstructured":"Saito, A. et al. Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int. Arch. Allergy Immunol. 132 (2), 168\u2013176. https:\/\/doi.org\/10.1159\/000073718 (2003).","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"2","key":"54625_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1165\/ajrcmb.23.2.3999","volume":"23","author":"DI Blyth","year":"2000","unstructured":"Blyth, D. I. et al. Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody. Am. J. Respir Cell. Mol. Biol. 23 (2), 241\u2013246. https:\/\/doi.org\/10.1165\/ajrcmb.23.2.3999 (2000).","journal-title":"Am. J. Respir Cell. Mol. Biol."},{"key":"54625_CR31","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.3389\/fphar.2019.01384","volume":"10","author":"S Lederer","year":"2019","unstructured":"Lederer, S., Dijkstra, T. M. H. & Heskes, T. Additive dose response models: Defining synergy. Front. Pharmacol. 10, 1384. https:\/\/doi.org\/10.3389\/fphar.2019.01384 (2019).","journal-title":"Front. Pharmacol."},{"issue":"51","key":"54625_CR32","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.1038\/sj.onc.1203148","volume":"18","author":"P Kriebel","year":"1999","unstructured":"Kriebel, P. et al. Consequences of Stat6 deletion on Sis\/PDGF- and IL-4-induced proliferation and transcriptional activation in murine fibroblasts. Oncogene 18 (51), 7294\u20137302. https:\/\/doi.org\/10.1038\/sj.onc.1203148 (1999).","journal-title":"Oncogene"},{"issue":"6","key":"54625_CR33","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.4049\/jimmunol.177.6.4141","volume":"177","author":"JL Ingram","year":"2006","unstructured":"Ingram, J. L. et al. Opposing actions of Stat1 and Stat6 on IL-13-induced up-regulation of early growth response-1 and platelet-derived growth factor ligands in pulmonary fibroblasts. J. Immunol. 177 (6), 4141\u20134148. https:\/\/doi.org\/10.4049\/jimmunol.177.6.4141 (2006).","journal-title":"J. Immunol."},{"issue":"21","key":"54625_CR34","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1007\/s00018-018-2899-4","volume":"75","author":"M Michalik","year":"2018","unstructured":"Michalik, M. et al. Fibroblast-to-myofibroblast transition in bronchial asthma. Cell. Mol. Life Sci. 75 (21), 3943\u20133961. https:\/\/doi.org\/10.1007\/s00018-018-2899-4 (2018).","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"54625_CR35","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1067\/mai.2003.1557","volume":"111","author":"J Chakir","year":"2003","unstructured":"Chakir, J. et al. Airway remodeling-associated mediators in moderate to severe asthma: Effect of steroids on TGF-\u03b2, IL-11, IL-17, and type I and type III collagen expression. J. Allergy. Clin. Immunol. 111(6), 1293\u20131298. https:\/\/doi.org\/10.1067\/mai.2003.1557 (2003).","journal-title":"J. Allergy. Clin. Immunol."},{"key":"54625_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6645072","volume":"2021","author":"K Bajbouj","year":"2021","unstructured":"Bajbouj, K., Ramakrishnan, R. K. & Hamid, Q. Role of matrix metalloproteinases in angiogenesis and its implications in asthma.. J. Immunol. Res. 6645072. https:\/\/doi.org\/10.1155\/2021\/6645072 (2021).","journal-title":"J. Immunol. Res."},{"issue":"3","key":"54625_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jaci.2011.04.047","volume":"128","author":"S Al-Muhsen","year":"2011","unstructured":"Al-Muhsen, S., Johnson, J. R. & Hamid, Q. Remodeling in asthma.. J. Allergy Clin. Immunol. (3), 451\u201362. https:\/\/doi.org\/10.1016\/j.jaci.2011.04.047 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"54625_CR38","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.4049\/jimmunol.170.4.2083","volume":"170","author":"F Huaux","year":"2003","unstructured":"Huaux, F. et al. Dual roles of IL-4 in lung injury and fibrosis. J. Immunol. 170 (4), 2083\u20132092. https:\/\/doi.org\/10.4049\/jimmunol.170.4.2083 (2003).","journal-title":"J. Immunol."},{"issue":"2","key":"54625_CR39","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1183\/09031936.00223411","volume":"41","author":"E Piper","year":"2013","unstructured":"Piper, E. et al. A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma. Eur. Respir J. 41 (2), 330\u2013338. https:\/\/doi.org\/10.1183\/09031936.00223411 (2013).","journal-title":"Eur. Respir J."},{"issue":"9","key":"54625_CR40","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S2213-2600(15)00197-6","volume":"3","author":"CE Brightling","year":"2015","unstructured":"Brightling, C. E. et al. Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: A randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir. Med. 3(9), 692\u2013701. https:\/\/doi.org\/10.1016\/S2213-2600(15)00197-6 (2015).","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"54625_CR41","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.alit.2024.02.002","volume":"73","author":"T Tajiri","year":"2024","unstructured":"Tajiri, T. et al. Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: A prospective, observational study. Allergol. Int. 73 (3), 406\u2013415. https:\/\/doi.org\/10.1016\/j.alit.2024.02.002 (2024).","journal-title":"Allergol. Int."},{"issue":"3","key":"54625_CR42","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.4049\/jimmunol.166.3.1716","volume":"166","author":"R Andrews","year":"2001","unstructured":"Andrews, R. et al. Reconstitution of a functional human type II IL-4\/IL-13 receptor in mouse B cells: demonstration of species specificity. J. Immunol. 166 (3), 1716\u20131722. https:\/\/doi.org\/10.4049\/jimmunol.166.3.1716 (2001).","journal-title":"J. Immunol."},{"issue":"4","key":"54625_CR43","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1165\/ajrcmb.19.4.3208","volume":"19","author":"GR Dubois","year":"1998","unstructured":"Dubois, G. R. et al. Human eosinophils constitutively express a functional interleukin-4 receptor: interleukin-4 -induced priming of chemotactic responses and induction of PI-3 kinase activity. Am. J. Respir Cell. Mol. Biol. 19 (4), 691\u2013699. https:\/\/doi.org\/10.1165\/ajrcmb.19.4.3208 (1998).","journal-title":"Am. J. Respir Cell. Mol. Biol."},{"issue":"5","key":"54625_CR44","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/s0091-6749(98)70029-6","volume":"102","author":"TC Kotsimbos","year":"1998","unstructured":"Kotsimbos, T. C. et al. Expression of the IL-4 receptor alpha-subunit is increased in bronchial biopsy specimens from atopic and nonatopic asthmatic subjects. J. Allergy Clin. Immunol. 102 (5), 859\u2013866. https:\/\/doi.org\/10.1016\/s0091-6749(98)70029-6 (1998).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"54625_CR45","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1172\/JCI741","volume":"101","author":"C Doucet","year":"1998","unstructured":"Doucet, C. et al. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J. Clin. Invest. 101 (10), 2129\u20132139. https:\/\/doi.org\/10.1172\/JCI741 (1998).","journal-title":"J. Clin. Invest."},{"issue":"10","key":"54625_CR46","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1006\/cyto.1998.0365","volume":"10","author":"VH van der Velden","year":"1998","unstructured":"van der Velden, V. H. et al. Interleukin 4 receptors on human bronchial epithelial cells. An in vivo and in vitro analysis of expression and function. Cytokine 10 (10), 803\u2013813. https:\/\/doi.org\/10.1006\/cyto.1998.0365 (1998).","journal-title":"Cytokine"},{"issue":"1","key":"54625_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cyto.2015.05.023","volume":"75","author":"SM McCormick","year":"2015","unstructured":"McCormick, S. M. & Heller, N. M. Commentary: IL-4 and IL-13 receptors and signaling. Cytokine 75 (1), 38\u201350. https:\/\/doi.org\/10.1016\/j.cyto.2015.05.023 (2015).","journal-title":"Cytokine"},{"issue":"6","key":"54625_CR48","doi-asserted-by":"publisher","first-page":"294","DOI":"10.5662\/wjm.v11.i6.294","volume":"11","author":"T Vilibic-Cavlek","year":"2021","unstructured":"Vilibic-Cavlek, T. et al. Comparison of indirect immunofluorescence and western blot method in the diagnosis of hantavirus infections. World J. Methodol. 11 (6), 294\u2013301. https:\/\/doi.org\/10.5662\/wjm.v11.i6.294 (2021).","journal-title":"World J. Methodol."},{"issue":"3","key":"54625_CR49","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1172\/JCI118829","volume":"98","author":"RL Palmer-Crocker","year":"1996","unstructured":"Palmer-Crocker, R. L., Hughes, C. C. & Pober, J. S. IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. J. Clin. Investig. 98 (3), 604\u2013609. https:\/\/doi.org\/10.1172\/JCI118829 (1996).","journal-title":"J. Clin. Investig."},{"issue":"5","key":"54625_CR50","doi-asserted-by":"publisher","first-page":"384","DOI":"10.2174\/156652408785161032","volume":"8","author":"DA Kuperman","year":"2008","unstructured":"Kuperman, D. A. & Schleimer, R. P. Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma. Curr. Mol. Med. 8 (5), 384\u2013392. https:\/\/doi.org\/10.2174\/156652408785161032 (2008).","journal-title":"Curr. Mol. Med."},{"issue":"4","key":"54625_CR51","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1067\/mai.2001.113760","volume":"107","author":"M Kraft","year":"2001","unstructured":"Kraft, M. et al. IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma. J. Allergy Clin. Immunol. 107 (4), 602\u2013606. https:\/\/doi.org\/10.1067\/mai.2001.113760 (2001).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"54625_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0014-4835(02)00248-8","volume":"76","author":"Y Fujitsu","year":"2003","unstructured":"Fujitsu, Y. et al. IL-4-induced cell proliferation and production of extracellular matrix proteins in human conjunctival fibroblasts. Exp. Eye Res. 76 (1), 107\u2013114. https:\/\/doi.org\/10.1016\/s0014-4835(02)00248-8 (2003).","journal-title":"Exp. Eye Res."},{"issue":"5","key":"54625_CR53","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1165\/rcmb.2016-0379OC","volume":"58","author":"CJ Philp","year":"2018","unstructured":"Philp, C. J. et al. Extracellular matrix cross-linking enhances fibroblast growth and protects against matrix proteolysis in lung fibrosis. Am. J. Respir Cell. Mol. Biol. 58(5), 594\u2013603. https:\/\/doi.org\/10.1165\/rcmb.2016-0379OC (2018).","journal-title":"Am. J. Respir Cell. Mol. Biol."},{"key":"54625_CR54","doi-asserted-by":"publisher","first-page":"25066","DOI":"10.1038\/srep25066","volume":"6","author":"S O\u2019Reilly","year":"2016","unstructured":"O\u2019Reilly, S. et al. IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics. Sci. Rep. 6, 25066. https:\/\/doi.org\/10.1038\/srep25066 (2016).","journal-title":"Sci. Rep."},{"issue":"12","key":"54625_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052332","volume":"7","author":"JR Bailey","year":"2012","unstructured":"Bailey, J. R. et al. IL-13 promotes collagen accumulation in Crohn\u2019s disease fibrosis by down-regulation of fibroblast MMP synthesis: A role for innate lymphoid cells?. PLoS One (12), e52332. https:\/\/doi.org\/10.1371\/journal.pone.0052332 (2012).","journal-title":"PLoS One"},{"issue":"2","key":"54625_CR56","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1183\/09031936.00068712","volume":"43","author":"R Firszt","year":"2014","unstructured":"Firszt, R. et al. Interleukin-13 induces collagen type-1 expression through matrix metalloproteinase-2 and transforming growth factor-\u03b21 in airway fibroblasts in asthma. Eur. Respir. J. 43 (2), 464\u2013473. https:\/\/doi.org\/10.1183\/09031936.00068712 (2014).","journal-title":"Eur. Respir. J."},{"issue":"6","key":"54625_CR57","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/1523-1747.ep12331160","volume":"107","author":"HA Makhluf","year":"1996","unstructured":"Makhluf, H. A. et al. IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts. J. Invest. Dermatol. 107 (6), 856\u2013859. https:\/\/doi.org\/10.1111\/1523-1747.ep12331160 (1996).","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"54625_CR58","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.4049\/jimmunol.152.7.3606","volume":"152","author":"GD Sempowski","year":"1994","unstructured":"Sempowski, G. D. et al. Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J. Immunol. 152 (7), 3606\u20133614 (1994).","journal-title":"J. Immunol."},{"issue":"3 Pt 1","key":"54625_CR59","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1164\/ajrccm.156.3.9610084","volume":"156","author":"A Laitinen","year":"1997","unstructured":"Laitinen, A. et al. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am. J. Respir. Crit Care Med. 156 (3 Pt 1), 951\u2013958. https:\/\/doi.org\/10.1164\/ajrccm.156.3.9610084 (1997).","journal-title":"Am. J. Respir. Crit Care Med."},{"key":"54625_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/biology12020199","author":"C Donovan","year":"2023","unstructured":"Donovan, C. et al. Tenascin C in lung diseases.. Biology https:\/\/doi.org\/10.3390\/biology12020199 (2023).","journal-title":"Biology"},{"issue":"2","key":"54625_CR61","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1164\/ajrccm.160.2.9809040","volume":"160","author":"J Huang","year":"1999","unstructured":"Huang, J. et al. Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am. J. Respir Crit. Care Med. 160 (2), 725\u2013729. https:\/\/doi.org\/10.1164\/ajrccm.160.2.9809040 (1999).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"6","key":"54625_CR62","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1006\/cyto.2002.1972","volume":"19","author":"N Yuyama","year":"2002","unstructured":"Yuyama, N. et al. Analysis of novel disease-related genes in bronchial asthma. Cytokine 19 (6), 287\u2013296. https:\/\/doi.org\/10.1006\/cyto.2002.1972 (2002).","journal-title":"Cytokine"},{"issue":"19","key":"54625_CR63","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1093\/hmg\/ddi311","volume":"14","author":"A Matsuda","year":"2005","unstructured":"Matsuda, A. et al. Coding SNP in tenascin-C Fn-III-D domain associates with adult asthma. Hum. Mol. Genet. 14 (19), 2779\u20132786. https:\/\/doi.org\/10.1093\/hmg\/ddi311 (2005).","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"54625_CR64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00011-024-01991-5","volume":"74","author":"KS Al-Sheakly","year":"2025","unstructured":"Al-Sheakly, K. S. Intranasal dupilumab improves responsiveness to steroid in an asthma mouse model. Inflamm. Res. 74 (1), 43. https:\/\/doi.org\/10.1007\/s00011-024-01991-5 (2025).","journal-title":"Inflamm. Res."},{"issue":"9","key":"54625_CR65","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/thorax.58.9.772","volume":"58","author":"NJ Kenyon","year":"2003","unstructured":"Kenyon, N. J. et al. TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice. Thorax 58 (9), 772\u2013777. https:\/\/doi.org\/10.1136\/thorax.58.9.772 (2003).","journal-title":"Thorax"},{"issue":"5","key":"54625_CR66","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jaci.2011.06.017","volume":"128","author":"A Kilic","year":"2011","unstructured":"Kilic, A. et al. Nerve growth factor induces type III collagen production in chronic allergic airway inflammation. J. Allergy Clin. Immunol. 128 (5), 1058\u20131066. https:\/\/doi.org\/10.1016\/j.jaci.2011.06.017 (2011). e1-4.","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"54625_CR67","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1172\/JCI14136","volume":"110","author":"S Lanone","year":"2002","unstructured":"Lanone, S. et al. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and \u2013\u200912 in IL-13-induced inflammation and remodeling. J. Clin. Invest. 110 (4), 463\u2013474. https:\/\/doi.org\/10.1172\/JCI14136 (2002).","journal-title":"J. Clin. Invest."},{"issue":"6","key":"54625_CR68","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jaci.2007.02.011","volume":"119","author":"X Zhou","year":"2007","unstructured":"Zhou, X. et al. Mechanisms of tissue inhibitor of metalloproteinase 1 augmentation by IL-13 on TGF-\u03b21\u2013stimulated primary human fibroblasts. J. Allergy Clin. Immunol. 119(6), 1388\u201397. https:\/\/doi.org\/10.1016\/j.jaci.2007.02.011 (2007).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"54625_CR69","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4168\/aair.2023.15.4.451","volume":"15","author":"TBT Cao","year":"2023","unstructured":"Cao, T. B. T. et al. Tissue inhibitor of metalloproteinase-1 enhances eosinophilic airway inflammation in severe asthma. Allergy Asthma Immunol. Res. 15(4), 451\u2013472. https:\/\/doi.org\/10.4168\/aair.2023.15.4.451 (2023).","journal-title":"Allergy Asthma Immunol. Res."},{"issue":"4","key":"54625_CR70","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1084\/jem.20100023","volume":"208","author":"C Perkins","year":"2011","unstructured":"Perkins, C. et al. Selective stimulation of IL-4 receptor on smooth muscle induces airway hyperresponsiveness in mice. J. Exp. Med. 208 (4), 853\u2013867. https:\/\/doi.org\/10.1084\/jem.20100023 (2011).","journal-title":"J. Exp. Med."},{"issue":"2","key":"54625_CR71","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.chest.2023.10.046","volume":"165","author":"S Hansen","year":"2024","unstructured":"Hansen, S. et al. Clinical response and remission in patients with severe asthma treated with biologic therapies. Chest 165(2), 253\u2013266. https:\/\/doi.org\/10.1016\/j.chest.2023.10.046 (2024).","journal-title":"Chest"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54625-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54625-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54625-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:32:08Z","timestamp":1786401128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54625-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54625"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54625-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Bassam Mahboub has received research support from Sanofi pertaining to the present study.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24753"}}